Mitochondria and left ventricular hypertrophy

Journal of Geriatric Cardiology

Volumn 5, Issue 1, 2008, Pages 50-59

  Zhu, Haiyan ^b   Wang, Shiwen ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; BIOENERGY; BIOGENESIS; ECHOCARDIOGRAPHY; GENETIC SUSCEPTIBILITY; HEART HEMODYNAMICS; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MISSENSE MUTATION; MITOCHONDRIAL VOLUME; MITOCHONDRION; NUCLEOTIDE SEQUENCE; OXIDATIVE PHOSPHORYLATION; PHENOTYPE; POINT MUTATION; PROTEIN SYNTHESIS; REVIEW;

EID: 58349114985     PISSN: 16715411     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (88)

1. Julien J, Tranche C, Souchet T.Left ventricular hypertrophy in hypertensive patients. Epidemiology and prognosis .Arch Mal Coeur Vaiss 2004.97(3):221-227 (Pubitemid 38428775)
2. Devereux, R.B Detection of left ventricular hypertrophy by M-mode echocardiography. An atomic validation, standardization, and comparison to other methods. Hypertension 1987;9 (Suppl II):II-19-II-26.
3. Hu,CG, Cai,S. The diagnosis and pathological mechanism of left ventricular hypertrophy in hypertensives. Chin J Crit Care Med 1997;17:55-56.
4. Coca A, De la Sierra A. Salt sensitivity and left ventricular hypertrophy. Adv Exp Med Biol 1997;432:91-101. (Pubitemid 28036000)
5. Vourvouri EC, Poldermans D, Schinkel AF, Koroleva LY, Sozzi FB, Parharidis GE, Bax JJ, Roelandt JR. Left ventricular hypertrophy screening using a hand-held ultrasound device. Eur Heart J 2002;23(19):1516-1521 (Pubitemid 35216718)
6. Post WS, Larson MG, Myers RH, Galderisi M, Levy D. Heritability of left ventricular mass: the Framingham Heart Study. Hypertension 1997;30(5):1025-1028 (Pubitemid 27476153)
7. Brendan DAT, McLaughlin MG, Kapuscinski MK, Jacob HJ, Harrap SB. Independent genetic susceptibility to cardiac hypertrophy in inherited hypertension.Hypertension 1998; 31(3): 741-746
8. Tsujita Y, Iwai N, Tamaki S, Nakamura Y, Nishimura M, Kinoshita M. Genetic mapping of quantitative trait loci influencing left ventricular mass in rats.Am J Physiol Heart Circ Physiol 2000 ;279(5):H2062-H2067.
9. Ahmad F, Seidman JG, Seidman CE.The genetic basis for cardiac remodeling.Annu Rev Genomics Hum Genet 2005;6: 185-216.
10. Zeviani M, Bonilla E, Devivo DC, Dimauro S. Mitochondrial diseases. Neurol Clin 1989; 7:123-156 (Pubitemid 19061978)
11. DiMauro S, Moraes CT. Mitochondrial encephalomyopathies. Arch Neurol 1993; 50:1197-1208 (Pubitemid 23327777)
12. Singh MM, Sinha A. Mitochondrial diseases: relevance to a physician. Postgrad Med 1998; 12:148-161
13. Vladutiu GD. Advances in the genetic mechanism of mitochondrial diseases. Curr Opin Neurol 1997; 10:512-518 (Pubitemid 27511051)
14. Holt IJ, Harding AE, Morgan-Hughes JA. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 1988; 331: 717-719 (Pubitemid 18062238)
15. Wallace DC, Singh G, Lott MT et al. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 1988; 242: 1427-1430
16. Harris DA, Das AM.Control of mitochondrial ATP synthesis in the heart. Biochem J 1991;280:561-573
17. Hirano M, DiMauro S: Clinical features of mitochondrial myopathies and encephalomyopathies. In Handbook of Muscle Disease. Edited by Lane RJM. New York: Marcel Dekker Inc. USA 1996;479-504.
18. Moraes CT, Shanske S, Tritschler HJ, et al.: MtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases. Am J Hum Genet 1991, 48:492-501.
19. Alemi M, Prigione A, Wong A, Schoenfeld R, DiMauro S, Hirano M, Taroni F,Cortopassi G. Mitochondrial DNA deletions inhibit proteasomal activity and stimulate an autophagic transcript. Free Radic Biol Med 2007 1;42(1):32-43.
20. Moraes CT, Ciacci F, Silvestri G, et al. Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA. Neuromusc Disord 1993, 3:43-50.
21. van den Ouweland JM, Lemkes HH, Ruitenbeek W, Sandkuijl LA, de Vijlder MF,Struyvenberg PA, van de Kamp JJ, Maassen JA. Mutation in mitochondrial tRNA(Leu)(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness.Nat Genet 1992 ;1(5):368-371
22. Aon MA, Cortassa S, Akar FG, O'Rourke B. Mitochondrial criticality: a new concept at the turning point of life or death. Biochim Biophys Acta 2006 ;1762(2):232-240 (Pubitemid 43006029)
23. Hattori K, Tanaka M, Sugiyama S et al. Age-dependent increase in deleted mitochondrial DNA in the human heart: possible contributory factor to presbycardia. Am Heart J 1991; 121: 1735-1742
24. Melov S, Shoffner JM, Kaufman A, Wallace DC. Marked increase in the number and variety of mitochondrial DNA rearrangements in aging human skeletal muscle. Nucl Acids Res 1995; 23: 4122-4126
25. Clayton D, Williams R, Liang I. Meeting highlights: mitochondrial DNA mutations and cardiomyopathy, heart failure, and ischemic heart disease.Circulation 1995;92:2022-2023
26. Ide T, Tsutsui H, Hayashidani S, Kang D, Suematsu N, Nakamura K, Utsumi H, Hamasaki N, Takeshita A. Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction. Circ Res 2001;88(5): 529-535 (Pubitemid 32240917)
27. Laine H, Katoh C, Luotolahti M, Yki-Järvinen H,, Kantola I, Jula A, Takala TO,Ruotsalainen U, Iida H, Haaparanta M, Nuutila P, Knuuti J. Myocardial oxygen consumption is unchanged but efficiency is reduced in patients with essential hypertension and left ventricular hypertrophy. Circulation 1999;100(24):2425-2430
28. Majamaa-Voltti, K, Peuhkurinen, K, Kortelainen, ML, Hassinen, IE, Majamaa, K.Cardiac abnormalities in patients with mitochondrial DNA mutation 3243A>G. BMC Cardiovasc Disord 2002;2:12.
29. Zhou L, Wan DF, Zhang GY, Li HN, Zhang PP, Zhao XT, Gu JR, Liew CC. Cloning, expression and mutation of mitochondrial ATPase gene of hypertensive patients and rats.Acta 1999; 21:729-732
30. Corona P, Lamantea E, Greco M, Carrara F, Agostino A, Guidetti D, Dotti MT, Mariotti C, Zeviani M. Novel heteroplasmic mtDNA mutation in a family with heterogeneous clinical presentations. Ann. Neurol 2002;51:118-122
31. Merante T, Myint T, Benson L, Robinson BH. An additional mitochondrial tRNA-ile point mutation(A-to-G at nucleotide 4295) causing hypertrophic cardiomyopathy. Hum. Mutat 1996; 8: 216-222
32. Degoul F, Brule H, Cepanec C, Helm M, Marsac C, Leroux JP, Giege R, Florentz C. Isoleucylation properties of native human mitochondrial tRNA-ile transcripts: implications for cardiomyopathy-related point mutations(4269,4317) in the tRNA-ile gene. Hum Mol. Genet 1998;7:347-354
33. Taylor RW, Giordano C, Davidson MM, d'Amati G, Bain H, Hayes CM, Leonard H, Barron MJ, Casali C, Santorelli FM, Hirano M, Lightowlers RN, Dimauro S, Turnbull, DM.A homoplasmic mitochondrial transfer ribonucleic acid mutation as a cause of maternally inherited hypertrophic cardiomyopathy. J Am Coll Cardiol 2003;41:1786-1796
34. Manfredi G, Vu TH, Bonilla E, et al. Association of myopathy with largescale mitochondrial DNA duplications and deletions: which is pathogenic? Ann Neurol 1997; 42:180-188
35. Tang Y, Manfredi G, Hirano M, Schon EA: Maintenance of human rearranged mitochondrial DNAs in long-term cultured transmitochondrial cell lines. Mol Biol Cell 2000; 11:2349-2358 (Pubitemid 30489919)
36. Fromenty B, Carrozzo R, Shanske S, et al: High proportions of mtDNA duplications in patients with Kearns-Sayre syndrome occur in the heart. Am J Med Genet 1997;71:443-452 (Pubitemid 27371845)
37. Morgan-Hughes JA, Mair WG. Atypical muscle mitochondria in oculoskeletal myopathy.Brain 1973;96(2):215-224
38. McComish M, Compston A, Jewitt D. Cardiac abnormalities in chronic progressive external ophthalmoplegia. Br Heart J 1976; 38(5): 526-529
39. Wallace DC. Mitochondrial defects in cardiomyopathy and neuromuscular disease.Am Heart J 2000;139:S70-S85.
40. Gollob MH, Green MS, Tang AS, Gollob T, Karibe A, Ali Hassan AS, Ahmad F, Lozado R, Shah G, Fananapazir L, Bachinski LL, Roberts R. Identification of a gene responsible for familial Wolff- Parkinson-White syndrome. N Engl J Med 2001;344:1823-1831 (Pubitemid 32538695)
41. Arad M, Benson DW, Perez-Atayde AR, McKenna WJ, Sparks EA, Kanter RJ, McGarry K, Seidman JG, Seidman CE. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy.J Clin Invest 2002;109:357-362
42. Hirano M, DiMauro S: Clinical features of mitochondrial myopathies and encephalomyopathies. In Handbook of Muscle Disease. Edited by Lane RJM. New York: Marcel Dekker Inc. USA 1996:479-504.
43. Anan R, Nakagawa M, Miyata M, et al.: Cardiac involvement in mitochondrial diseases. A study of 17 patients with mitochondrial DNA defects. Circulation 1995;91:955-961
44. Ozawa M, Nishino I, Horai S, et al. Myoclonus epilepsy associated with ragged-red fibers: a G-to-A mutation at nucleotide pair 8363 in mitochondrial tRNA(Lys) in two families. Muscle Nerve 1997;20:271-278
45. Shtilbans A, Shanske S, Goodman S, et al.: G8363A mutation in the mitochondrial DNA transfer ribonucleic acid Lys gene: another cause of Leigh syndrome. J Child Neurol 2000;15:759-761
46. Santorelli FM, Mak SC, El-Schahawi M, et al.: Maternally inherited cardiomyopathy and hearing loss associated with a novel mutation in the mitochondrial tRNA(Lys) gene (G8363A). Am J Hum Genet 1996;58:933-939
47. Sato W, Tanaka M, Sugiyama S, et al. Cardiomyopathy and angiopathy in pat ient s wi th mi tochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. Am Heart J 1994;128:733-741 (Pubitemid 24314662)
48. Pavlakis SG, Phillips PC, DiMauro S, et al.: Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol 1984;16: 481-488
49. Goto Y, Nonaka I, Horai S: A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990;348:651-653 (Pubitemid 120015131)
50. Hirano M, Pavlakis S Mitochondrial myopathy, encephalopathy, lactic acidosis,and strokelike episodes (MELAS): current concepts. J Child Neurol 1994;9:4-13. (Pubitemid 24022131)
51. Suzuki Y, Harada K, Miura Y, et al. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) decrease in diastolic left ventricular function assessed by echocardiography. Pediatr Cardiol 1993;14:162-166 (Pubitemid 23178940)
52. Okajima Y, Tanabe Y, Takayanagi M, et al.: A follow up study of myocardial involvement in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS). Heart 1998;80:292-295
53. Moraes CT, Ciacci F, Silvestri G, et al. Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA. Neuromusc Disord 1993;3:43-50.
54. Silvestri G, Bertini E, Servidei S, et al.: Maternally inherited cardiomyopathy: a new phenotype associated with the A to G AT nt.3243 of mitochondrial DNA (MELAS mutation). Muscle Nerve 1997;20:221-225
55. Vilarinho L, Santorelli FM, Rosas MJ, et al.: The mitochondrial A3243G mutation presenting as severe cardiomyopathy. J Med Genet 1997;34:607-609
56. Hiruta Y, Chin K, Shitomi K, et al.: Mitochondrial encephalomyopathy with A to G transition of mitochondrial transfer RNA(Leu(UUR)) 3243 presenting hypertrophic cardiomyopathy. Intern Med 1995;34:670-673
57. Kawarai T, Kawakami H, Kozuka K, et al.: A new mitochondrial DNA mutation associated with mitochondrial myopathy: tRNALeu(UUR) 3254 C-to-G. Neurology 1997;49:598-600.
58. Zeviani M, Gellera C, Antozzi C, et al.Maternally inherited myopathy and cardiomyopathy:association with mutation in mitochondrial DNA tRNA(Leu)(UUR).Lancet 1991;338:143-247.
59. Nishino I, Komatsu M, Kodama S, et al.: The 3260 mutation in mitochondrial DNA can cause mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS). Muscle Nerve 1996;19:1603-1604
60. Silvestri G, Santorelli FM, Shanske S, et al.: A new mtDNA mutation in the tRNA(LeuUUR) gene associated with maternally inherited cardiomyopathy. Hum Mut 1994;3:37-43.
61. Mitsuoka T, Kawarai T, Watanabe C, et al. Comparison of clinical pictures of mitochondrial encephalomyopathy with tRNA(Leu(UUR)) mutation in 3243 with that in 3254 No To Shinkei 1998;50:1089-1092
62. Bruno C, Kirby DM, Koga Y, et al.: The mitochondrial DNA C3303T mutation can cause cardiomyopathy and/or skeletal myopathy. J Pediatr 1999;135:197-202
63. Santorelli FM, El-Shahawi M, Shanske S, et al.: A novel mtDNA mutation associated with human cardiomyopathy. Circulation. 1995;92(suppl 1):232-233
64. Casali C, Santorelli FM, D'Amati G, et al.: A novel mtDNA point mutation in maternally inherited cardiomyopathy. Biochem Biophys Res Comm 1995;213:588-593
65. Tanaka M, Ino H, Ohno K, Hattori K, Sato W, Ozawa T, et al. Mitochondrial mutation in fatal infantile cardiomyopathy. Lancet 1990; 2:1452.
66. Ile mutation in fatal cardiomyopathy. Biochem Biophys Res Comm 1992;186:47-53.
67. Silvestri G, Ciafaloni E, Santorelli F, et al. Clinical features associated with the A>G transition at nucleotide 8344 of mtDNA ("MERRF mutation"). Neurology 1993; 43:1200-1206
68. Pastores G, Santorelli FM, Shanske S, et al.: Leigh syndrome and hypertrophic cardiomyopathy in an infant with a mitochondrial DNA point mutation (T8993G). Am J Med Genet. 1994; 50:265-271
69. Merante F, Tein I, Benson L, et al: Maternally inherited hypertrophic cardiomyopathy due to a novel T-to-C transition at nucleotide 9997 in the mitochondrial tRNAglycine gene. Am J Hum Genet 1994;55:437-446 (Pubitemid 24272397)
70. Valnot I, Kassis J, Chretien D, et al. A mitochondrial cytochrome b mutation but no mutations of nuclearly encoded subunits in ubiquinol cytochrome c reductase (complex III) deficiency. Hum Genet 1999;104:460-466
71. Levinger L, Morl M, Florentz C. Mitochondrial tRNA 3′ end metabolism and human disease.Nucleic Acids Res 2004;32(18): 5430-5441
72. Kelley S, Steinberg S, Schimmel P. Functional defects of pathogenic human mitochondrial tRNAs related to structural fragility. Nature Struct. Biol 2000, 7: 862-865
73. Kelley SO, Steinberg SV, Schimmel P. Fragile T-stem in disease-associated human mitochondrial tRNA sensitizes structure to local and distant mutations. J. Biol. Chem 2001; 276:10607-10611
74. Sohm B, Frugier M, Brule H, Olszak K, Przykorska A, Florentz C.Towards understanding human mitochondrial leucine aminoacylation identity. J Mol Biol 2003;328:995-1010. (Pubitemid 36506870)
75. Wilson FH, Hariri A, Farhi A, Zhao H, Petersen KF, Toka HR, Nelson-Williams C, Raja KM, Kashgarian M, Shulman GI, Scheinman SJ, Lifton RP. A cluster of metabolic defects caused by mutation in a mitochondrial tRNA. Science 2004;306(5699): 1190-1194 (Pubitemid 39489000)
76. van den Bosch BJ, Lindsey PJ, van den Burg CM, van der Vlies SA, Lips DJ, van der,Vusse GJ, Ayoubi TA, Doevendans PA, Smeets HJ. Early and transient gene expression changes in pressure overload-induced cardiac hypertrophy in mice.Genomics 2006;88(4):480-488
77. Takimoto E, Champion HC, Li M, et al. Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load. J Clin Invest 2005; 115: 1221-1231
78. Siwik DA, Pagano PJ, Colucci WS. Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts. Am J Physiol Cell Physiol 2001; 280: C53-60. (Pubitemid 32523398)
79. Sawyer DB, Siwik D, Xiao L, Pimentel DR, Singh K, Colucci WS. Role of oxidative stress in myocardial hypertrophy and failure.J Mol Cell Cardiol 2002; 34: 379-388
80. Ichinose F, Bloch KD, Wu JC, et al. Pressure overload-induced LV hypertrophy and dysfunction in mice are exacerbated by congenital NOS3 deficiency. Am J Physiol Heart Circ Physiol 2004;286: H1070-5.
81. Ruetten H, Dimmeler S, Gehring D, Ihling C, Zeiher AM. Concentric left ventricular remodeling in endothelial nitric oxide synthase knockout mice by chronic pressure overload. Cardiovasc Res 2005; 66: 444-453 (Pubitemid 40725756)
82. Opie LH, Commerford PJ, Gersh BJ, Pfeffer MA. Controversies in ventricular remodelling. Lancet 2006;367(9507):356-367 (Pubitemid 43151469)
83. Gronholm T, Finckenberg T, Palojoki E, Saraste A, Backlund T, Eriksson A, Laine M, Mervaala E, Tikkanen I. Cardioprotective effects of vasopeptidase inhibition in vs angiotensin type 1-receptor blockade in spontaneously hypertensive rat on a high salt diet. Hypertens Res 2004;27:609-618.
84. Fortuño MA, Ravassa S. Apoptosis in hypertensive heart disease. Curr Opin Cardiol 1998;13(5):317-325 (Pubitemid 28508736)
85. Hirano M, Davidson M, DiMauro S. Mitochondria and the heart. Curr Opin Cardiol 2001;16(3):201-210 (Pubitemid 32493660)
86. France-Lanord V, Brugg B, Michel PP, Agid Y, Ruberg M. Mitochondrial free radical signal in ceramide-dependent apoptosis: a putative mechanism for neuronal death in Parkinson's disease. J Neurochem 1997;69(4):1612-1621 (Pubitemid 27406962)
87. Graff C, Clayton DA, Larsson NG. Mitochondrial medicine - recent advances.J Intern Med 1999 ;246(1):11-23.
88. Schapira AH. Mitochondrial disease.Lancet 2006;368(9529): 70-82.